Face to Face Top Stocks: NexPoint Residential Trust, Inc. (NYSE:NXRT), Sierra Oncology, Inc. (NASDAQ:SRRA)

NexPoint Residential Trust, Inc. (NYSE:NXRT)

NexPoint Residential Trust, Inc. (NYSE:NXRT) closed at $35.42 on the last trading session with an decrease of -1.25%, whereas, it previously closed at $35.87. The company has a market capitalization of $812.89 Million. The company traded shares of 45340 on the trading day while its three month average volume stands at 97.44 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of NexPoint Residential Trust, Inc. (NYSE:NXRT) produced diluted EPS of -0.08. The EPS estimate for next year as estimated by analysts is at 0.45 while EPS for next quarter is estimated at -0.08. Earnings per Share growth for this year is reported at -103, while the analysts estimated the EPS growth for next year at 0.45% and Earnings growth for next 5 years stands at 5% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at -56.9%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of NexPoint Residential Trust, Inc. (NYSE:NXRT) is at 0 while the forward p/e is at 78.71. The P/S or Price to Sales ratio of NexPoint Residential Trust, Inc. (NYSE:NXRT) stands at 5.54 and Price to Book or P/B for the most recent quarter stands at 2.66. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of NexPoint Residential Trust, Inc. (NYSE:NXRT) are reported at 0 and 0 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for NexPoint Residential Trust, Inc. (NYSE:NXRT) stands at -0.1, -0.6 and 1.2 respectively

The trailing twelve month Revenue of NexPoint Residential Trust, Inc. (NYSE:NXRT) is reported at 146.6 Million with income of -1600000. The outstanding shares of NexPoint Residential Trust, Inc. (NYSE:NXRT) are 22.95 Million. The institutional Ownership of the shares of 68.7 stands at 0.80%, this figure is increased 20.15 in the last six months. The insider ownership for the shares of NexPoint Residential Trust, Inc. (NYSE:NXRT) is ticked at 1.1%, the figure is rose 0% in the last six months.

Some other important financial aspects to be discussed here for NexPoint Residential Trust, Inc. (NYSE:NXRT) is the Mean Target Price estimated by the analysts which stands at 41.36. The 52 week high of NexPoint Residential Trust, Inc. (NYSE:NXRT) is placed at 38.70 and 52 week low is standing at 23.75.

Performance wise the shares of NexPoint Residential Trust, Inc. (NYSE:NXRT) rose up 2.58% for the week, it also fell -6.67% for the monthly performance, while for the quarter it went up -2.13%. The shares increase 12.3% for the half year and flew up for the Year-To-Date performance. The shares of NexPoint Residential Trust, Inc. (NYSE:NXRT) grew 39.45% for the yearly performance.

Sierra Oncology, Inc. (NASDAQ:SRRA)

Sierra Oncology, Inc. (NASDAQ:SRRA) closed at $1.9 on the last trading session with an increase of 3.83%, whereas, it previously closed at $1.83. The company has a market capitalization of $143.81 Million. The company traded shares of 160503 on the trading day while its three month average volume stands at 265.3 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Sierra Oncology, Inc. (NASDAQ:SRRA) produced diluted EPS of -0.76. The EPS estimate for next year as estimated by analysts is at -1.04 while EPS for next quarter is estimated at -0.21. Earnings per Share growth for this year is reported at -8.1, while the analysts estimated the EPS growth for next year at -1.04% and Earnings growth for next 5 years stands at 0% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at -53.6%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Sierra Oncology, Inc. (NASDAQ:SRRA) is at 0 while the forward p/e is at 0. The P/S or Price to Sales ratio of Sierra Oncology, Inc. (NASDAQ:SRRA) stands at 0 and Price to Book or P/B for the most recent quarter stands at 1.5. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of Sierra Oncology, Inc. (NASDAQ:SRRA) are reported at 10.8 and 10.8 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Sierra Oncology, Inc. (NASDAQ:SRRA) stands at -43.1, -47.1 and 0 respectively

The trailing twelve month Revenue of Sierra Oncology, Inc. (NASDAQ:SRRA) is reported at 0 with income of -53300000. The outstanding shares of Sierra Oncology, Inc. (NASDAQ:SRRA) are 75.69 Million. The institutional Ownership of the shares of 67.1 stands at 0.80%, this figure is increased 5.98 in the last six months. The insider ownership for the shares of Sierra Oncology, Inc. (NASDAQ:SRRA) is ticked at 0.1%, the figure is rose 0% in the last six months.

Some other important financial aspects to be discussed here for Sierra Oncology, Inc. (NASDAQ:SRRA) is the Mean Target Price estimated by the analysts which stands at 6.67. The 52 week high of Sierra Oncology, Inc. (NASDAQ:SRRA) is placed at 3.70 and 52 week low is standing at 1.05.

Performance wise the shares of Sierra Oncology, Inc. (NASDAQ:SRRA) rose up 3.26% for the week, it also rise 26.67% for the monthly performance, while for the quarter it went down 31.03%. The shares increase 6.74% for the half year and flew up for the Year-To-Date performance. The shares of Sierra Oncology, Inc. (NASDAQ:SRRA) shrinked -20.17% for the yearly performance.